About the Journal
Attention:
We know that specific organisations assert they are associated with us for publication. This is to notify all users and interested parties that the Drug Discovery and Molecular Docking (DDMD) is not associated with, affiliated with, or under contract with any of these organisations or outside consulting firms. Additionally, we discovered that unsanctioned email addresses purporting to communicate on our behalf may occasionally be seen. Please exercise caution, as any correspondence you get from email addresses that we have yet to approve officially may not be authentic. We neither support such a representation nor take accountability for acts outside our formal communication channels. Please use the formal channels listed on our website to contact us directly if you have any questions or issues regarding the veracity of a communication you have received.
About Journal
Drug Discovery and Molecular Docking (DDMD) is an International, Peer-reviewed, Open-access journal dedicated to advancing research in computational drug design, molecular docking, and pharmaceutical sciences. Our mission is to provide a platform for scientists, researchers, and industry professionals to share groundbreaking discoveries that enhance drug development and therapeutic innovations.
Scope and Focus
DDMD covers a wide range of topics, including:
- Molecular Docking & Simulation – Computational approaches for predicting ligand-target interactions.
- Drug Design & Development – Novel methodologies for identifying and optimizing drug candidates.
- AI & Machine Learning in Drug Discovery – Integrating advanced algorithms for precision medicine.
- Pharmacokinetics & Pharmacodynamics – Understanding drug behavior at molecular and systemic levels.
- Biomolecular Interactions – Exploring protein-ligand binding mechanisms for therapeutic applications.
Commitment to Excellence
We uphold rigorous peer-review standards to ensure the originality, quality, and impact of published research. Our editorial board consists of leading experts in pharmaceutical sciences, computational chemistry, and biomedical engineering, fostering interdisciplinary collaboration.
Why Publish with DDMD?
- High Visibility – Indexed in major scientific databases for global reach.
- Rapid Publication – Streamlined review process for timely dissemination of research.
- Innovative Research – Focus on emerging trends in drug discovery and molecular modeling.
DDMD is committed to bridging the gap between computational methodologies and experimental validation, driving forward the future of pharmaceutical research.
The Journal of Drug Discovery and Molecular Docking (DDMD) (JIELS) is published Bimonthly in the last week of February, April, June, August, October and December.
